Home LiteratureArticle Details
PMID: 14609953 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.

The EMBO journal ·Vol. 22 ·No. 22 ·2003-11-17 ·Pages 6068-77

Rubbi CP, Milner J

Abstract

p53 protects against cancer through its capacity to induce cell cycle arrest or apoptosis under a large variety of cellular stresses. It is not known how such diversity of signals can be integrated by a single molecule. However, the literature reveals that a common denominator in all p53-inducing stresses is nucleolar disruption. We thus postulated that the impairment of nucleolar function might stabilize p53 by preventing its degradation. Using micropore irradiation, we demonstrate that large amounts of nuclear DNA damage fail to stabilize p53 unless the nucleolus is also disrupted. Forcing nucleolar disruption by anti-upstream binding factor (UBF) microinjection (in the absence of DNA damage) also causes p53 stabilization. We propose that the nucleolus is a stress sensor responsible for maintenance of low levels of p53, which are automatically elevated as soon as nucleolar function is impaired in response to stress. Our model integrates all known p53-inducing agents and also explains cell cycle-related variations in p53 levels which correlate with established phases of nucleolar assembly/disassembly through the cell cycle.

MeSH Terms
Cell Nucleolus/metabolism DNA Damage/physiology Humans Tumor Suppressor Protein p53/metabolism
Chemicals
Tumor Suppressor Protein p53
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rubbi Carlos P
YCR P53 Research Group, Department of Biology, University of York, York YO10 5DD, UK. cpr2@york.ac.uk
Milner Jo
References (64)
64 references, click to expand
  1. Lack of transcription-coupled repair in mammalian ribosomal RNA genes.
    Biochemistry. 1993 Oct 5;32(39):10512-8 PMID: 8399197
  2. Heat shock disassembles the nucleolus and inhibits nuclear protein import and poly(A)+ RNA export.
    EMBO J. 1996 Dec 2;15(23):6750-7 PMID: 8978700
  3. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.
    Mol Cell Biol. 1994 Sep;14(9):6264-77 PMID: 8065358
  4. U.v.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle.
    Oncogene. 1994 Oct;9(10):2775-84 PMID: 8084582
  5. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes.
    Mol Cell Biol. 1994 Nov;14(11):7414-20 PMID: 7935455
  6. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.
    Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8876-80 PMID: 7568035
  7. Protein p53 modulates transcription from a promoter containing its binding site in a concentration-dependent manner.
    Eur J Biochem. 1995 Dec 15;234(3):827-31 PMID: 8575441
  8. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
    Cancer Res. 1996 Apr 1;56(7):1674-81 PMID: 8603419
  9. Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains.
    Exp Cell Res. 1996 Apr 10;224(1):163-73 PMID: 8612682
  10. Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
    Cancer Lett. 1996 Feb 27;100(1-2):191-7 PMID: 8620441
  11. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage.
    Genes Dev. 1996 Apr 15;10(8):934-47 PMID: 8608941
  12. Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.
    Oncogene. 1999 Dec 9;18(52):7409-22 PMID: 10602500
  13. Mechanisms of switching on p53: a role for covalent modification?
    Oncogene. 1999 Dec 13;18(53):7666-75 PMID: 10618706
  14. The ARF/p53 pathway.
    Curr Opin Genet Dev. 2000 Feb;10(1):94-9 PMID: 10679383
  15. An information-intensive approach to the molecular pharmacology of cancer.
    Science. 1997 Jan 17;275(5298):343-9 PMID: 8994024
  16. p53, the cellular gatekeeper for growth and division.
    Cell. 1997 Feb 7;88(3):323-31 PMID: 9039259
  17. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1795-9 PMID: 9050858
  18. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2.
    Oncogene. 1997 Apr 17;14(15):1859-68 PMID: 9150392
  19. Cytoplasmic p53 polypeptide is associated with ribosomes.
    Mol Cell Biol. 1997 Jun;17(6):3146-54 PMID: 9154813
  20. Li-Fraumeni syndrome--a molecular and clinical review.
    Br J Cancer. 1997;76(1):1-14 PMID: 9218725
  21. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.
    Curr Biol. 1997 Nov 1;7(11):860-9 PMID: 9382809
  22. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
    EMBO J. 1998 Jan 15;17(2):554-64 PMID: 9430646
  23. Transcription abnormalities potentiate apoptosis of normal human fibroblasts.
    Mol Med. 1997 Dec;3(12):852-63 PMID: 9440118
  24. Interaction of the HIV-1 rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5.
    Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1607-12 PMID: 9465063
  25. p53 is a general repressor of RNA polymerase III transcription.
    EMBO J. 1998 Jun 1;17(11):3112-23 PMID: 9606193
  26. Cisplatin inhibits synthesis of ribosomal RNA in vivo.
    Nucleic Acids Res. 1998 Jun 15;26(12):2831-6 PMID: 9611224
  27. Impaired DNA repair capacity in skin fibroblasts from various hereditary cancer-prone syndromes.
    Mutat Res. 1998 Mar;407(2):189-201 PMID: 9637247
  28. Murine tumor suppressor models.
    Mutat Res. 1998 May 25;400(1-2):391-407 PMID: 9685699
  29. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    EMBO J. 1998 Sep 1;17(17):5001-14 PMID: 9724636
  30. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
    Mol Cell Biol. 1998 Dec;18(12):7288-93 PMID: 9819415
  31. Inhibition of RNA polymerase II as a trigger for the p53 response.
    Oncogene. 1999 Jan 21;18(3):583-92 PMID: 9989808
  32. p53 represses ribosomal gene transcription.
    Oncogene. 1999 Jan 28;18(4):1119-24 PMID: 10023689
  33. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.
    EMBO J. 1999 Mar 15;18(6):1660-72 PMID: 10075936
  34. DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation.
    Oncogene. 1999 Mar 4;18(9):1723-32 PMID: 10208433
  35. Cell cycle-dependent regulation of RNA polymerase I transcription: the nucleolar transcription factor UBF is inactive in mitosis and early G1.
    Proc Natl Acad Sci U S A. 1999 May 25;96(11):6096-101 PMID: 10339547
  36. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6937-41 PMID: 10359817
  37. Repression of RNA polymerase I transcription by the tumor suppressor p53.
    Mol Cell Biol. 2000 Aug;20(16):5930-8 PMID: 10913176
  38. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.
    Neoplasia. 2000 May-Jun;2(3):208-25 PMID: 10935507
  39. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
    Nat Cell Biol. 2000 Sep;2(9):563-8 PMID: 10980695
  40. Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress.
    J Cell Sci. 2001 May;114(Pt 10):1867-73 PMID: 11329373
  41. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition.
    Mol Cell Biol. 2001 Jul;21(13):4246-55 PMID: 11390653
  42. Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.
    Oncogene. 2001 Sep 20;20(42):5951-63 PMID: 11593402
  43. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53.
    Exp Cell Res. 2001 Oct 15;270(1):66-77 PMID: 11597128
  44. Genotoxic and non-genotoxic pathways of p53 induction.
    Cancer Lett. 2001 Dec 10;174(1):1-15 PMID: 11675147
  45. Local UV-induced DNA damage in cell nuclei results in local transcription inhibition.
    EMBO Rep. 2001 Nov;2(11):1013-7 PMID: 11713193
  46. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.
    Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):95-100 PMID: 11756653
  47. Directed proteomic analysis of the human nucleolus.
    Curr Biol. 2002 Jan 8;12(1):1-11 PMID: 11790298
  48. Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage.
    FASEB J. 2002 Mar;16(3):420-2 PMID: 11790725
  49. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
    Nat Cell Biol. 2002 Jun;4(6):462-7 PMID: 12032546
  50. Nucleophosmin regulates the stability and transcriptional activity of p53.
    Nat Cell Biol. 2002 Jul;4(7):529-33 PMID: 12080348
  51. The nucleolus--a gateway to viral infection?
    Arch Virol. 2002 Jun;147(6):1077-89 PMID: 12111420
  52. Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation.
    Mol Cell Biol. 2002 Aug;22(16):6014-22 PMID: 12138209
  53. p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage.
    EMBO J. 2003 Feb 17;22(4):975-86 PMID: 12574133
  54. Biogenesis and nuclear export of ribosomal subunits in higher eukaryotes depend on the CRM1 export pathway.
    J Cell Sci. 2003 Jun 15;116(Pt 12):2409-19 PMID: 12724356
  55. Control of nucleolar RNA synthesis by the intracellular pool sizes of ATP and GTP.
    Cell. 1976 Mar;7(3):447-53 PMID: 947552
  56. Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources.
    J Histochem Cytochem. 1977 Jul;25(7):935-41 PMID: 894009
  57. Ultrastructural and autoradiographic study of the effects of bleomycin on the interphase nucleus of cultured normal cells.
    Cancer Res. 1979 Oct;39(10):4218-23 PMID: 89895
  58. Ultrastructural changes in nucleoli and fibrillar centers under the effect of local ultraviolet microbeam irradiation of interphase culture cells.
    Exp Cell Res. 1989 Mar;181(1):94-104 PMID: 2917612
  59. The tumor suppressor p53 is bound to RNA by a stable covalent linkage.
    Mol Cell Biol. 1991 Mar;11(3):1598-606 PMID: 1705009
  60. Nucleolar protein B23 translocation after deferoxamine treatment in a human leukemia cell line.
    Int J Cancer. 1991 Jul 9;48(5):779-84 PMID: 2071236
  61. p53 is covalently linked to 5.8S rRNA.
    Mol Cell Biol. 1992 Nov;12(11):5145-51 PMID: 1406686
  62. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
    Oncogene. 1996 Jun 6;12(11):2267-78 PMID: 8649766
  63. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis.
    Oncogene. 1996 Aug 15;13(4):823-31 PMID: 8761304
  64. Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.
    Cancer Res. 1994 Feb 1;54(3):632-6 PMID: 8306322
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
2003-11-17
Pages
6068-77
Language
English
Region
England
NLM ID
8208664
PMCID
PMC275437
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com